Advertisement
Advertisement
VRCA
Verrica Pharmaceuticals Inc. Common Stock
5.85
USDSponsored
+0.20
+3.54%
Jun 24, 16:00 UTC -4
Closed
After-Market
5.92
+0.07
+1.20%
VRCA Earnings Reports
Positive Surprise Ratio
VRCA beat 17 of 32 last estimates.
53%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$6.10M
/-$0.38
Implied change from Q1 26 (Revenue/ EPS)
+42.26%
/-7.32%
Implied change from Q2 25 (Revenue/ EPS)
-51.95%
/-2000.00%
Verrica Pharmaceuticals Inc. Common Stock earnings per share and revenue
On May 12, 2026, VRCA reported earnings of -0.41 USD per share (EPS) for Q1 26, missing the estimate of -0.37 USD, resulting in a -10.72% surprise. Revenue reached 4.29 million, compared to an expected 4.61 million, with a -6.95% difference. The market reacted with a +3.08% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 6.10 million USD, implying an decrease of -7.32% EPS, and increase of 42.26% in Revenue from the last quarter.
FAQ
What were Verrica Pharmaceuticals Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Verrica Pharmaceuticals Inc. Common Stock reported EPS of -$0.41, missing estimates by -10.72%, and revenue of $4.29M, -6.95% below expectations.
How did the market react to Verrica Pharmaceuticals Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 3.08%, changed from $7.15 before the earnings release to $7.37 the day after.
When is Verrica Pharmaceuticals Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Verrica Pharmaceuticals Inc. Common Stock's next earnings report?
Based on 4
analysts, Verrica Pharmaceuticals Inc. Common Stock is expected to report EPS of -$0.38 and revenue of $6.10M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement